DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 33 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,787,349 | +2.8% | 390,167 | 0.0% | 0.03% | -5.7% |
| Q2 2023 | $4,658,594 | +31.4% | 390,167 | +47.1% | 0.04% | +12.9% |
| Q1 2023 | $3,545,283 | +15.0% | 265,167 | +85.1% | 0.03% | -3.1% |
| Q4 2022 | $3,082,051 | +8.3% | 143,218 | +0.8% | 0.03% | -3.0% |
| Q3 2022 | $2,847,000 | -26.8% | 142,143 | -34.5% | 0.03% | -25.0% |
| Q2 2022 | $3,887,000 | +279.6% | 217,143 | +110.4% | 0.04% | +300.0% |
| Q1 2022 | $1,024,000 | -41.1% | 103,200 | 0.0% | 0.01% | -45.0% |
| Q4 2021 | $1,739,000 | -29.0% | 103,200 | 0.0% | 0.02% | -33.3% |
| Q3 2021 | $2,449,000 | +4.2% | 103,200 | 0.0% | 0.03% | +11.1% |
| Q2 2021 | $2,350,000 | – | 103,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 2,548,403 | $54,841,633 | 43.06% |
| PATHWAY CAPITAL MANAGEMENT, LP | 995,686 | $21,427,163 | 38.24% |
| Atlas Venture Life Science Advisors, LLC | 7,568,317 | $162,870,182 | 19.62% |
| RA Capital Management | 7,040,622 | $151,514,185 | 3.07% |
| COMMODORE CAPITAL LP | 739,661 | $15,918 | 2.40% |
| GREAT POINT PARTNERS LLC | 544,451 | $11,716,586 | 2.30% |
| Nicholas Investment Partners, LP | 786,554 | $16,926,642 | 1.48% |
| Boxer Capital, LLC | 1,189,943 | $25,607,573 | 1.35% |
| Parkman Healthcare Partners LLC | 224,483 | $4,830,874 | 1.29% |
| Cheyne Capital Management (UK) LLP | 27,223 | $585,839 | 1.02% |